Abstract
Objective
To elucidate the role of transsphenoidal surgery in the treatment of pituitary microprolactinoma.
Methods
The clinical data of 107 prolactinoma cases treated by extra-pseudocapsular transnasal transsphenoidal surgery (ETTS) for different indications in our department since 2011 was retrospectively analyzed.
Results
The most common indication was the ineffectiveness of oral medication (41.1%), followed by the personal willingness of the patient (35.5%), and 20.6% of the patients were young women with clear tumor boundaries. The pseudocapsule was not observed in 63 cases (58.9%), incomplete pseudocapsule was observed in 26 cases (24.3%), and complete pseudocapsule in 18 cases (16.8%). A total of 97 patients (90.7%) obtained 1-year post-operation remission. According to the relative location of the adenoma and pituitary gland on the MRI scan, 46 patients were classified into a central type, 59 a lateral type, and 2 a supra-pituitary type. Two patients developed hypogonadism, one patient developed hypocortisolism, and one patient developed post-operative hypothyroidism. Two patients were administrated with hormone replacement treatment, and the treatment was stopped within one week. There was no permanent hypopituitarism. Further investigation demonstrated that the adenoma types could affect the remission rates of hyperprolactinemia and gross total resection rate in microprolactinoma.
Conclusion
ETTS was an effective treatment for pituitary microprolactinomas. This could be the first choice for patients who presented enclosed adenoma on the MRI and were potentially curable in a preoperative evaluation. Maximal safe removal of the adenoma by ETTS with the aim to increase the sensitivity of the drugs was also recommended for patients with invasive dopamine agonist resistant prolactinomas and patients with difficulty in childbirth.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Vroonen L, Daly AF, Beckers A. Epidemiology and Management Challenges in Prolactinomas. Neuroendocrinology, 2019,109(1):20–27
Giese S, Nasi-Kordhishti I, Honegger J. Outcomes of Transsphenoidal Microsurgery for Prolactinomas — A Contemporary Series of 162 Cases. Exp Clin Endocrinol Diabetes, 2021,129(3):163–171
Nomikos P, Buchfelder M, Fahlbusch R. Current management of prolactinomas. J Neuro-oncol, 2001, 54(2):139–150
Yan Z, Lei T. Hypogonadism in Male Patients with Pituitary Adenoma and Its Related Mechanism: A Review of Literature. Brain Sci, 2022,12(6):796
Wan X, Yan Z, Tan Z, et al. MicroRNAs in Dopamine Agonist-Resistant Prolactinoma. Neuroendocrinology, 2022,112(5):417–426
Salvatori R. Surgical treatment of microprolactinomas: pros. Endocrine, 2014,47(3):725–729
Caputo C, Prior D, Inder WJ. The need for annual echocardiography to detect cabergoline-associated valvulopathy in patients with prolactinoma: a systematic review and additional clinical data. Lancet Diabetes Endocrinol, 2015,3(11):906–913
Buchfelder M, Zhao Y, Schlaffer SM. Surgery for Prolactinomas to Date. Neuroendocrinology, 2019,109(1):77–81
Jho HD. Endoscopic transsphenoidal surgery. J Neurooncol, 2001,54(2):187–195
Honegger J, Nasi-Kordhishti I, Aboutaha N, et al. Surgery for prolactinomas: a better choice? Pituitary, 2020,23(1):45–51
Jethwa PR, Patel TD, Hajart AF, et al. Cost-Effectiveness Analysis of Microscopic and Endoscopic Transsphenoidal Surgery Versus Medical Therapy in the Management of Microprolactinoma in the United States. World Neurosurg, 2016,87:65–76
Casanueva FF, Molitch ME, Schlechte JA, et al. Guidelines of the Pituitary Society for the diagnosis and management of prolactinomas. Clin Endocrinol, 2006,65(2):265–273
Kreutzer J, Buslei R, Wallaschofski H, et al. Operative treatment of prolactinomas: indications and results in a current consecutive series of 212 patients. Eur J Endocrinol, 2008,158(1):11–18
Lu L, Wan X, Xu Y, et al. Classifying Pituitary Adenoma Invasiveness Based on Radiological, Surgical and Histological Features: A Retrospective Assessment of 903 Cases. J Clin Med, 2022,11(9):2464
Chen J, Guo X, Miao Z, et al. Extra-Pseudocapsular Transsphenoidal Surgery for Microprolactinoma in Women. J Clin Med, 2022,11(13):3920
Buchfelder M, Adams EF, Kiesewetter F, et al. Proliferation parameters for pituitary adenomas. Acta neurochir Suppl, 1996,65:18–21
Tampourlou M, Trifanescu R, Paluzzi A, et al. Therapy of endocrine disease: Surgery in microprolactinomas: effectiveness and risks based on contemporary literature. Eur J Endocrinol, 2016,175(3):R89–96
Losa M, Mortini P, Barzaghi R, et al. Surgical treatment of prolactin-secreting pituitary adenomas: early results and long-term outcome. J Clin Endocrinol Metabol, 2002,87(7):3180–3186
Oldfield EH, Vortmeyer AO. Development of a histological pseudocapsule and its use as a surgical capsule in the excision of pituitary tumors. J Neurosurg, 2006,104(1):7–19
Buchfelder M, Schlaffer SM, Zhao Y. The optimal surgical techniques for pituitary tumors. Best Pract Res Clin Endocrinol Metab, 2019,33(2):101299
Ikeda H, Watanabe K, Tominaga T, et al. Transsphenoidal microsurgical results of female patients with prolactinomas. Clin Neurol Neurosurg, 2013, 115(9): 1621–1625
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
The authors have declared no competing interests in this work.
Author Ting LEI is a member of the Editorial Board for Current Medical Science. The paper was handled by other editors and has undergone rigorous peer review process. Author Ting LEI was not involved in the journal’s review of, or decisions related to, this manuscript.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License https://creativecommons.org/licenses/by/4.0/), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/).
About this article
Cite this article
Wan, Xy., Li, Lh., Chen, J. et al. Surgical Technique and Efficacy Analysis of Extra-pseudocapsular Transnasal Transsphenoidal Surgery for Pituitary Microprolactinoma. CURR MED SCI 42, 1140–1147 (2022). https://doi.org/10.1007/s11596-022-2678-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11596-022-2678-1